Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
224.2 USD | +1.18% |
|
-1.45% | -12.77% |
03:00pm | Redburn Atlantic Adjusts Price Target on Biogen to $230 From $235, Maintains Neutral Rating | MT |
12:26pm | Goldman Sachs Adjusts Price Target on Biogen to $342 From $340, Maintains Buy Rating | MT |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-13.12% | 32.26B | |
+7.40% | 101B | |
+7.76% | 42.18B | |
+81.37% | 29.79B | |
-11.37% | 16.06B | |
+1.60% | 14.45B | |
-8.56% | 12.01B | |
+182.74% | 10.71B | |
+3.67% | 8.89B | |
-56.23% | 8.83B |
- Stock Market
- Equities
- BIIB Stock
- News Biogen Inc.
- Goldman Sachs Adjusts Price Target on Biogen to $342 From $340, Maintains Buy Rating